RBC
CLX icon

Roble Belko & Company’s Clorox CLX Stock Holding History

Roble Belko & Company’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$133K Buy
1,287
+12
+0.9% +$1.36K 0.02% 158
2025
Q4 		$129K Buy
1,275
+508
+66% +$55.2K 0.02% 151
2025
Q3 		$95K Buy
767
+204
+36% +$25.3K 0.01% 145
2025
Q2 		$68K Buy
563
+202
+56% +$26.9K 0.01% 161
2025
Q1 		$53K Buy
361
+211
+141% +$32.2K 0.01% 163
2024
Q4 		$24K Buy
+150
New +$24.5K ﹤0.01% 205

Other funds holding CLX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Roble Belko & Company's CLX Position: Q1 2026 in Review

Roble Belko & Company increased its Clorox (CLX) stake by 0.94% in Q1 2026, buying an estimated $1.36K and bringing the position to 1,287 shares worth $133K. The position accounts for 0.02% of the portfolio, ranked #158.

Roble Belko & Company first reported a position in CLX in Q4 2024 and has held it in 6 quarters since. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Roble Belko & Company held 1,287 shares of Clorox worth $133K as of Q1 2026.
  • Roble Belko & Company bought 12 Clorox shares in Q1 2026, an estimated $1.36K.
  • Clorox made up 0.02% of Roble Belko & Company's portfolio in Q1 2026, its #158 holding.
  • Roble Belko & Company first reported a position in Clorox in Q4 2024 and has held it in 6 quarters since.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Roble Belko & Company's 13F filing for Q1 2026, filed 16 Apr 2026.